TPF Plus Radiotherapy and Cetuximab to Avoid Total Laryngectomy in Patients With Larynx Cancer
Status:
Completed
Trial end date:
2015-05-12
Target enrollment:
Participant gender:
Summary
A Phase II Trial With Radiotherapy Plus Cetuximab to Evaluate Specific Survival Free of
Laryngectomy in Patients With Resectable and Locally Advanced Larynx Cancer, After Treatment
With TPF Chemotherapy.
Phase:
Phase 2
Details
Lead Sponsor:
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello